Literature DB >> 16883611

Decisional capacity in mental illness and substance use disorders: empirical database and policy implications.

Dilip V Jeste1, Elyn Saks.   

Abstract

Debates on decisional capacity in people with mental illnesses or substance use disorders have tended to be heated. Yet, they are often based not on empirical data but on personal opinions and experiences. The empirical database in this area is quite limited, but has been growing in recent years. The following discussion focuses on relevant clinical investigations. We consider variations across and within different diagnoses, barriers to decision-making, methods for assessing capacity-interview versus instruments, choosing from among different capacity instruments, decisional capacity-is it a state or a trait?, triggers for assessment of decisional capacity, methods for enhancing capacity, and decisional capacity in people with substance use disorders. Finally, we discuss some relevant health policy recommendations. Copyright (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2006        PMID: 16883611     DOI: 10.1002/bsl.707

Source DB:  PubMed          Journal:  Behav Sci Law        ISSN: 0735-3936


  14 in total

1.  Homeless women with schizophrenia reported lower adherence to their medication than men: results from the French Housing First experience.

Authors:  A Tinland; K Zemmour; P Auquier; M Boucekine; V Girard; S Loubière; G Fond; Laurent Boyer
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2017-06-27       Impact factor: 4.328

Review 2.  A systematic review of the Soteria paradigm for the treatment of people diagnosed with schizophrenia.

Authors:  Tim Calton; Michael Ferriter; Nick Huband; Helen Spandler
Journal:  Schizophr Bull       Date:  2007-06-14       Impact factor: 9.306

3.  Ethical and clinical safety considerations in the design of an effectiveness trial: A comparison of buprenorphine versus naltrexone treatment for opioid dependence.

Authors:  Edward V Nunes; Joshua D Lee; Dominic Sisti; Andrea Segal; Arthur Caplan; Marc Fishman; Genie Bailey; Gregory Brigham; Patricia Novo; Sarah Farkas; John Rotrosen
Journal:  Contemp Clin Trials       Date:  2016-09-28       Impact factor: 2.226

Review 4.  Proceed with caution: off-label ketamine treatment for major depressive disorder.

Authors:  Dominic Sisti; Andrea G Segal; Michael E Thase
Journal:  Curr Psychiatry Rep       Date:  2014-12       Impact factor: 5.285

5.  Awareness and Knowledge of Pre-exposure Prophylaxis Among Sexual and Gender Minority Adolescents Assigned Male at Birth in the United States.

Authors:  Margaret Matson; Mara Nery-Hurwit; Shariell Crosby; George J Greene; Kathryn Macapagal
Journal:  Arch Sex Behav       Date:  2021-05-12

6.  Fluctuating capacity and advance decision-making in Bipolar Affective Disorder - Self-binding directives and self-determination.

Authors:  Tania Gergel; Gareth S Owen
Journal:  Int J Law Psychiatry       Date:  2015-05-02

7.  Toward meeting the needs of homeless people with schizophrenia: the validity of quality of life measurement.

Authors:  Pascal Auquier; Aurelie Tinland; Cecile Fortanier; Anderson Loundou; Karine Baumstarck; Christophe Lancon; Laurent Boyer
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

8.  Validation of the Medication Adherence Rating Scale in homeless patients with schizophrenia: Results from the French Housing First experience.

Authors:  K Zemmour; A Tinland; M Boucekine; V Girard; S Loubière; N Resseguier; G Fond; P Auquier; L Boyer
Journal:  Sci Rep       Date:  2016-08-18       Impact factor: 4.379

9.  Decision-making capacity for research participation among addicted people: a cross-sectional study.

Authors:  Inés Morán-Sánchez; Aurelio Luna; Maria Sánchez-Muñoz; Beatriz Aguilera-Alcaraz; Maria D Pérez-Cárceles
Journal:  BMC Med Ethics       Date:  2016-01-13       Impact factor: 2.652

10.  Evaluation of the Housing First program in patients with severe mental disorders in France: study protocol for a randomized controlled trial.

Authors:  Aurelie Tinland; Cecile Fortanier; Vincent Girard; Christian Laval; Benjamin Videau; Pauline Rhenter; Tim Greacen; Bruno Falissard; Themis Apostolidis; Christophe Lançon; Laurent Boyer; Pascal Auquier
Journal:  Trials       Date:  2013-09-24       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.